Clinical factors associated with hyperkalemia in patients with congestive heart failure.
about
Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With HyperkalemiaHyperkalemia among hospitalized patients and association between duration of hyperkalemia and outcomes.The positive predictive value of a hyperkalemia diagnosis in automated health care dataElevated baseline potassium level within reference range is associated with worse clinical outcomes in hospitalised patientsDiabetes and drug-associated hyperkalemia: effect of potassium monitoring.Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis.Severe hyperkalemia requiring hospitalization: predictors of mortality.Type 2 diabetes mellitus and heart failure.What is the risk of hyperkalaemia in heart failure?Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.Treatment of Hyperkalemia in Heart Failure.Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure.Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia.Life-threatening drug-associated hyperkalemia: a retrospective study from laboratory signals.Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease.Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
P2860
Q28831139-05DB8369-56CB-46F6-95A1-CEF8DA79EC23Q33701269-D418B64C-0E75-4038-9067-7A62EB473290Q33705569-B2C305E5-32DF-475B-A200-488F1B98649BQ33729193-0153A4C8-C966-49CA-B5B7-B5E8E37D485EQ33742539-D3385F1B-1A54-43B7-B27E-9D7230DA55CAQ36712216-537E4B72-2569-450C-ADB4-1F8D63AD7D03Q36902782-B04D379E-CFF1-447B-8FBC-22A1665A93B1Q37069176-B1232A91-6EFB-49EC-A483-5D07C2B189FCQ37902667-D4276495-E4CE-4731-BE92-140A6B9AC85FQ37925006-C71D040B-C21C-49BD-A65E-DA33AFFAE831Q38705827-9EDAE65F-AF4D-4375-BB3A-9FA59E969989Q43210363-4124AA98-D986-49D7-886D-F6A51E8BED91Q43498899-9D7D0C9D-A075-4CDC-AA78-914F9DE2DF43Q46169733-84D75C28-3352-4078-BE53-4F77BC5BB518Q47252893-21D019B6-3CC3-499C-B66C-30CE74DAF309Q47741739-CCDBCA54-63EA-4C81-941B-F581ECCB3E66
P2860
Clinical factors associated with hyperkalemia in patients with congestive heart failure.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Clinical factors associated with hyperkalemia in patients with congestive heart failure.
@en
Clinical factors associated with hyperkalemia in patients with congestive heart failure.
@nl
type
label
Clinical factors associated with hyperkalemia in patients with congestive heart failure.
@en
Clinical factors associated with hyperkalemia in patients with congestive heart failure.
@nl
prefLabel
Clinical factors associated with hyperkalemia in patients with congestive heart failure.
@en
Clinical factors associated with hyperkalemia in patients with congestive heart failure.
@nl
P2860
P1476
Clinical factors associated with hyperkalemia in patients with congestive heart failure
@en
P2093
El-Solh AA
Ramadan FH
P2860
P304
P356
10.1111/J.1365-2710.2005.00638.X
P577
2005-06-01T00:00:00Z